NewsRoom Articles - Page 113 of 115

MondayJun 26, 2017 2:52 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targeting Blockbuster Therapeutics

The medical efficacy of cannabinoids to treat a multiplicity of maladies is no longer in doubt. Two recently published scientific studies dispelled any apprehensions about cannabis-based therapies. The highly respected New England Journal of Medicine published a peer reviewed article that proved in a controlled study that cannabidiol dramatically reduced the number of convulsive seizures in children stricken with a severe epileptic disorder (http://nnw.fm/i0X0D). The results of this study follow a comprehensive report by the National Academies of Science, Engineering, and Medicine which confirmed that cannabinoids are effective at treating chronic pain and for providing relief from nausea and vomiting…

ThursdayJun 22, 2017 3:41 pm

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Takes Additional Step toward Clinical Trials for INM-750

Moving toward offering the very first therapy for treating epidermolysis bullosa (EB), InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) recently announced it has signed an agreement with Pharmaseed Ltd. (http://nnw.fm/4lZzC) to develop a final formulation for INM-750, InMed’s lead compound, which is being developed as a therapy for EB and for other potential dermatological and wound-healing applications. EB is a group of inherited connective tissue diseases sharing a common manifestation of very fragile skin that is prone to easily blistering or tearing. An orphan disease that currently has no approved treatments and has significant unmet medical need, EB results from…

MondayJun 05, 2017 8:00 am

ABcann Global (TSXV: ABCN) Target Price Set At $2.25 as Coverage is Initiated

Now that shares of ABcann Global Corporation (TSXV: ABCN) are trading on the venture arm of the Toronto Stock Exchange (TSX), the company is creating more buzz than ever. On the same day it launched its initial public offering (IPO) (May 4), industry analysts PI Financial initiated coverage of the stock with a decidedly bullish report (http://nnw.fm/zcgG2) on the company. PI has put a “Buy” rating on the stock and set a one-year price target of $2.25, implying a return of well over 100 percent. The investment bank backs up this sunny prognosis with an in-depth look at ABcann’s value…

ThursdayJun 01, 2017 8:43 am

ABcann Medicinals (TSXV: ABCN) Eyes Growing Role on Canadian Marijuana Market, Extends Agreement with MMJ Pioneer

One of the most dominant and experienced growers of quality medical marijuana on the Canadian market, ABcann Medicinals (TSXV: ABCN), has entered a stage of aggressive growth after launching its first initial public offering (IPO) on the TSX Venture Exchange earlier this month. Recently acquired by ABcann Global Corporation, an acquisition that came with a $26.8 million capital raise to help expand production, the company is already licensed to sell to the entire Canadian market and plans to significantly expand production to reach this goal. In addition, ABcann also plans to sign partnerships to sell to the U.S. market, as…

MondayMay 08, 2017 2:55 pm

ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing

Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange. Although the IPO was just launched on May 4 (http://nnw.fm/Lt5DO), its value took off, soaring over 26% on the first day and trading over 25% of the total volume on the exchange. ABcann is one of Canada’s major legal cannabis producers, and the public offers are set to provide even more investor benefits as the recreational marijuana market is now positioned for nationwide legalization. Raising capital was part of the company’s decision…

WednesdayMay 03, 2017 1:04 pm

ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO

All eyes are on ABcann Medicinals, Inc. as it prepares to go public. The company, which is already growing rapidly, wants to expand its footprint in Canada and take advantage of potential international opportunities. Additional production facilities are planned to meet the expected supply short fall in the Canadian market when marijuana for recreational use is legalized next year. With its state-of-the-art cultivation facilities and established patient-client care systems, ABcann has the infrastructure in place to profit from that billion-dollar Canadian marijuana market. With adult use of marijuana set for legalization by July 1, 2018, the Canadian marijuana market is…

TuesdayMay 02, 2017 2:20 pm

ABcann Medicinals Set to Launch IPO This Week on TSXV

According to efficient markets theory, the chances of finding hundred-dollar bills lying on the ground are slim, at best. When one is dropped, some well-informed investor is quick to pick it up. However, with Abcann Medicinals set to launch its initial public offering (IPO) on the TSX Venture Exchange on May 4, the chances of finding those elusive hundreds have increased significantly. Investors will have an opportunity to take up shares in one of Canada’s major legal cannabis producers. With the marijuana recreational market in Canada set for legalization, the Abcann Medicinals IPO will level the playing field and offer…

ThursdayDec 08, 2016 12:00 pm

Signal Bay (SGBY) Starts Presentation at LD Micro Main Event

Signal Bay (OTC: SGBY) provides advisory, management and analytical testing services to the legalized cannabis industry in the United States. The company offers industry research; business and market intelligence; and advisory and consulting services, including license application support, regulatory compliance, market forecasts and operational insights. It also publishes industry information through online media, research reports and publications, and operates CANNAiQ.com, a business to business information portal, as well as MarijuanaMath.com, a general interest informational website. For more information, visit the company's website at www.signalbay.com. About CanadianCannabisWire CanadianCannabisWire (CNW) provides news aggregation and syndication, enhanced press release services and a full…

TuesdayDec 06, 2016 6:30 pm

Kush Bottles (KSHB) Starts Presentation at LD Micro Main Event

Kush Bottles (OTCQB: KSHB) provides packaging products and solutions to producers, processers and retailers operating in the regulated medical and recreational cannabis industry. Founded in 2010, the company has sold more than 100 million bottles and regularly services thousands of customers across the United States and Canada. The company primarily services the business-to-business market, which includes legally operated medical and adult-use dispensaries, growers and marijuana-infused product (MIP) manufacturers. Kush Bottles has no direct involvement with cannabis plants or extracts. For more information, visit the company's website at www.kushbottles.com. About CanadianCannabisWire CanadianCannabisWire (CNW) provides news aggregation and syndication, enhanced press release…

TuesdayDec 06, 2016 6:00 pm

Omni-Lite Industries (OLNCF) Starts Presentation at LD Micro Main Event

Omni-Lite Industries (OTC: OLNCF) develops precision components utilizing advanced composite materials and computer-controlled cold forging techniques. The company's early success came from the sports and recreation industry where its ultra-lightweight ceramic composite track spikes quickly became the industry standard used by most of the world's elite athletes. Omni-Lite has since broadened its product offerings to include products for the automotive, commercial, aerospace, and military markets. The company develops and manufactures precision components utilized by several Fortune 500 Companies including Boeing, Airbus, Alcoa, Ford, Caterpillar, Borg Warner, Chrysler, the U.S. Military, Nike and Adidas. For more information, visit the company's website…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000